3rd Quarter - Report
PODESTA GROUP, INC. for VIROPHARMA INCORPORATED
Firm
Client
Income
$40,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. FDA regulation of antibiotics, plasma derivatives, and rare diseases.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHEN NORTHRUP | — |
| THOMAS B SPARKMAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.